Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial

(2018) Pascal Vranckx et al.   AMERICAN HEART JOURNAL

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial

(2018) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Concomitant Use of Antiplatelets and Anticoagulants in Patients with Coronary Heart Disease and Atrial Fibrillation: What Do Recent Clinical Trials Teach Us?

(2018) David H. Lam et al.   Current Atherosclerosis Reports

Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation

(2018) Daniele Pastori et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA 2 DS 2 -VASc score in the entire Korean population

(2017) So-Ryoung Lee et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials

(2017) George Ntaios et al.   International Journal of Stroke

Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents

(2017) Hyo-In Choi et al.   JACC-Cardiovascular Interventions

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

(2017) So-Ryoung Lee et al.   PLoS One

Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis

(2017) Xiaoxuan Gong et al.   PLoS One

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2016) Dominick J. Angiolillo et al.   Circulation-Cardiovascular Interventions

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Underweight is a risk factor for atrial fibrillation: A nationwide population-based study

(2016) Si-Hyuck Kang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: A nationwide population-based study

(2016) So-Ryoung Lee et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2016) Nadia R. Sutton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service

(2016) Yong-ho Lee et al.   Diabetes & Metabolism Journal

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

(2015) Kang-Ling Wang et al.   STROKE

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

(2014) et al.   EUROPEAN HEART JOURNAL

Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System

(2014) Sun Ok Song et al.   Diabetes & Metabolism Journal

Warfarin use among older atrial fibrillation patients with non–ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy

(2013) Emil L. Fosbol et al.   AMERICAN HEART JOURNAL

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

(2013) Morten Lamberts et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention

(2012) Morten Lamberts et al.   CIRCULATION

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

(2012) Antonio L. Dans et al.   CIRCULATION

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Triple antithrombotic management after stent implantation: when and how?

(2009) A. Schomig et al.   HEART

Periprocedural Management and In-Hospital Outcome of Patients with Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting

(2009) ANDREA RUBBOLI et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy

(2008) Roberta Rossini et al.   AMERICAN JOURNAL OF CARDIOLOGY